Works matching AU Daniels, Jacob


Results: 11
    1
    2
    3
    4

    Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19.

    Published in:
    Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29413-2
    By:
    • Liu, Hengrui;
    • Iketani, Sho;
    • Zask, Arie;
    • Khanizeman, Nisha;
    • Bednarova, Eva;
    • Forouhar, Farhad;
    • Fowler, Brandon;
    • Hong, Seo Jung;
    • Mohri, Hiroshi;
    • Nair, Manoj S.;
    • Huang, Yaoxing;
    • Tay, Nicholas E. S.;
    • Lee, Sumin;
    • Karan, Charles;
    • Resnick, Samuel J.;
    • Quinn, Colette;
    • Li, Wenjing;
    • Shion, Henry;
    • Xia, Xin;
    • Daniels, Jacob D.
    Publication type:
    Article
    5

    Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19.

    Published in:
    Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29413-2
    By:
    • Liu, Hengrui;
    • Iketani, Sho;
    • Zask, Arie;
    • Khanizeman, Nisha;
    • Bednarova, Eva;
    • Forouhar, Farhad;
    • Fowler, Brandon;
    • Hong, Seo Jung;
    • Mohri, Hiroshi;
    • Nair, Manoj S.;
    • Huang, Yaoxing;
    • Tay, Nicholas E. S.;
    • Lee, Sumin;
    • Karan, Charles;
    • Resnick, Samuel J.;
    • Quinn, Colette;
    • Li, Wenjing;
    • Shion, Henry;
    • Xia, Xin;
    • Daniels, Jacob D.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11